856
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Donor lymphocyte infusions to leukemic bone lesions are therapeutically effective in a Ph+ ALL patient with post-HSCT relapse

, , , , , , & show all
Pages 347-352 | Received 09 Dec 2013, Accepted 06 Feb 2014, Published online: 10 Mar 2014

Figures & data

Figure 1. Magnetic resonance imaging: coronal proton density fat saturation image (Cor PD-fs FSE) (normal bone is grey while that infiltrated and vascularized becomes bright; fat signal suppression improves the contrast in fat-rich tissues). Note the nodular pattern of signal and decrease in signal intensity along intra-bone and intravenous DLI procedure (106 MNC/kg BW separated from a primary HSCT donor) using a Cobe Spectra continuous flow separator (COBE BCT inc., Blood Component Technology, Lakewood, CO). Above, the clinical data are provided.

Figure 1. Magnetic resonance imaging: coronal proton density fat saturation image (Cor PD-fs FSE) (normal bone is grey while that infiltrated and vascularized becomes bright; fat signal suppression improves the contrast in fat-rich tissues). Note the nodular pattern of signal and decrease in signal intensity along intra-bone and intravenous DLI procedure (106 MNC/kg BW separated from a primary HSCT donor) using a Cobe Spectra continuous flow separator (COBE BCT inc., Blood Component Technology, Lakewood, CO). Above, the clinical data are provided.

Figure 2. Positive aspiration biopsies for blast cells in the right tibia and in right head of the humerus.

Figure 2. Positive aspiration biopsies for blast cells in the right tibia and in right head of the humerus.

Figure 3. Marrow cell profiling for CD3+ lymphocytes and those CD28+ or HLADR+. Left panels represent analysis made at the time of IB DLI; right ones after completion of this therapy, just prior to the relapse.

Figure 3. Marrow cell profiling for CD3+ lymphocytes and those CD28+ or HLADR+. Left panels represent analysis made at the time of IB DLI; right ones after completion of this therapy, just prior to the relapse.

Figure 4. Perforin+ lymphocytes in the marrow after completion of IB DLI prior to relapse.

Figure 4. Perforin+ lymphocytes in the marrow after completion of IB DLI prior to relapse.

Figure 5. A representative marrow smear (performed after two IB DLI) with a focus on macrophages phagocytizing cellular remnants.

Figure 5. A representative marrow smear (performed after two IB DLI) with a focus on macrophages phagocytizing cellular remnants.

Figure 6. Trephine biopsy taken at the beginning of relapse. Note CD8+ cell (red) in close proximity to Ki67+ blasts (left panel) and IL-17-producing cells (right panel).

Figure 6. Trephine biopsy taken at the beginning of relapse. Note CD8+ cell (red) in close proximity to Ki67+ blasts (left panel) and IL-17-producing cells (right panel).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.